Chilton Capital Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Chilton Capital Management's LLY Position: Q2 2026 in Review
Chilton Capital Management reduced its Eli Lilly (LLY) stake by 9.1% in Q2 2026, selling an estimated $7.1M and leaving 69,286 shares worth $83.1M. The position accounts for 2.62% of the portfolio, ranked #10.
Chilton Capital Management first reported a position in LLY in Q2 2013 and has held it in 24 quarters since. 4,626 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Chilton Capital Management held 69,286 shares of Eli Lilly worth $83.1M as of Q2 2026.
- Chilton Capital Management sold 6,945 Eli Lilly shares in Q2 2026, an estimated $7.1M.
- Eli Lilly made up 2.62% of Chilton Capital Management's portfolio in Q2 2026, its #10 holding.
- Chilton Capital Management first reported a position in Eli Lilly in Q2 2013 and has held it in 24 quarters since.
- 4,626 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Chilton Capital Management's 13F filing for Q2 2026, filed 4 Aug 2026.